We are live on ! Find out more
HLVX

HilleVax
HLVX

Delisted

HLVX was delisted on the 16th of September, 2025.

Back to rankings

57 hedge funds and large institutions have $254M invested in HilleVax in 2022 Q2 according to their latest regulatory filings, with 57 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

69.47% more ownership

Funds ownership: 0% → 69.47% (+69%)

Holders
57
Holders Change
+57
Holders Change %
–
% of All Funds
0.96%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
57
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FLSM
Frazier Life Sciences Management
California
+$110M
2
DM
Deerfield Management
New York
+$31.1M
3
A
Abingworth
United Kingdom
+$21.8M
4
RCM
RA Capital Management
Massachusetts
+$20.9M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$13.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
FLSM
1
Frazier Life Sciences Management
California
$101M +$110M +9,285,682 New
DM
2
Deerfield Management
New York
$28.6M +$31.1M +2,617,948 New
A
3
Abingworth
United Kingdom
$19.9M +$21.8M +1,838,486 New
RCM
4
RA Capital Management
Massachusetts
$19.2M +$20.9M +1,760,019 New
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$12M +$13.1M +1,101,237 New
PA
6
Perceptive Advisors
New York
$8.36M +$9.08M +764,907 New
SB
7
Samsara BioCapital
California
$8.34M +$9.06M +762,577 New
BlackRock
8
BlackRock
New York
$8.06M +$8.75M +737,182 New
SG
9
StepStone Group
California
$7.39M +$8.03M +676,567 New
Franklin Resources
10
Franklin Resources
California
$7.35M +$7.99M +672,512 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$6.68M +$7.25M +610,807 New
QUSVM
12
Qiming U.S. Ventures Management
Washington
$6.11M +$6.64M +558,923 New
BI
13
BVF Inc
California
$4.18M +$4.54M +382,513 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$2.4M +$2.61M +219,507 New
State Street
15
State Street
Massachusetts
$1.79M +$1.95M +164,172 New
Two Sigma Investments
16
Two Sigma Investments
New York
$1.42M +$1.54M +130,000 New
FAM
17
Fred Alger Management
New York
$1.18M +$1.28M +107,710 New
Northern Trust
18
Northern Trust
Illinois
$1.15M +$1.24M +104,745 New
Morgan Stanley
19
Morgan Stanley
New York
$1.14M +$1.24M +104,102 New
UOC
20
UBS O'Connor
Illinois
$994K +$1.08M +90,943 New
Charles Schwab
21
Charles Schwab
California
$991K +$1.08M +90,665 New
GCM
22
Ghisallo Capital Management
Massachusetts
$656K +$712K +60,000 New
Alyeska Investment Group
23
Alyeska Investment Group
Illinois
$462K +$502K +42,312 New
SGM
24
Seven Grand Managers
New York
$376K +$408K +34,386 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$344K +$375K +31,544 New
1
2 3

HLVX Hedge Fund Activity: Q2 2022 in Review

57 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q2 2022, worth a combined $254M.

Buyers outnumbered sellers: 57 funds opened new HLVX positions and 0 closed out — a net gain of 57 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Frazier Life Sciences Management, opening a new position worth an estimated $110M.

  • 57 institutional investors held HilleVax (HLVX) as of Q2 2022, up from 0 in Q1 2022.
  • Funds reported $254M of HilleVax stock for Q2 2022.
  • 57 funds opened new HilleVax positions in Q2 2022 and 0 closed out, a net change of +57 holders.
  • The largest HilleVax buyer in Q2 2022 was Frazier Life Sciences Management, an estimated $110M added.

Based on aggregated 13F filings for Q2 2022.